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Fragile X syndrome is themost common form of
inherited mental retardation in humans, with an
estimated prevalence of about 1 in 4000 males.
Although several observations indicate that the
absence of functional Fragile XMental Retarda-
tion Protein (FMRP) is the underlying basis of
Fragile X syndrome, the structure and function
of FMRP are currently unknown. Here, we pres-
ent an X-ray crystal structure of the tandem KH
domains of human FMRP, which reveals the rel-
ative orientation of the KH1 and KH2 domains
and the location of residue Ile304, whose muta-
tion to Asn is associated with a particularly
severe incidence of Fragile X syndrome. We
show that the Ile304Asnmutation both perturbs
the structure and destabilizes the protein.
INTRODUCTION
Fragile X Mental Retardation Protein (FMRP) is expressed
at high levels in the central nervous system and genitalia
(Tamanini et al., 1997). Intracellularly, FMRP localizes pre-
dominantly in the cytoplasm (Devys et al., 1993), where it
has been reported to associate with transcribing ribo-
somes; low levels of FMRP are also detectable in the nu-
cleolus (Jin and Warren, 2000). The sequence of FMRP
provides hints to its function. FMRP contains nuclear
localization and nuclear export signals (NLS and NES)
(Eberhart et al., 1996), tandem K-homology domains
(KH1 and KH2) (Siomi et al., 1993), and an RGG box
(Figure 1A). However, despite significant experimental
efforts, the in vivo activity of FMRP remains unclear, with
roles in nuclear-cytoplasmic shuttling of RNA, transla-
tional control, dendritic transport of RNA, and dendrite-
specific regulation of translation all having been proposed
(Jin and Warren, 2000; Eberhart et al., 1996; Khandjian
et al., 2004; Antar et al., 2005).1090 Structure 15, 1090–1098, September 2007 ª2007 ElsevierHumans and othermammals have two autosomal paral-
ogs of FMRP: Fragile X Related Proteins 1 and 2 (FXRP1
and FXRP2), which have similar domain organization and
expression patterns to FMRP. Their functions are also
unknown. Animals in other phyla either have no homologs
of FMRP or have a single FMRP-like ortholog, as seen, for
example, in amphibians and arthropods (Figure 1B).
The most common cause of Fragile X syndrome is an
expansion of CGG repeats upstream of the gene that
encodes FMRP, and the consequent silencing of gene
expression essentially eliminates production of FMRP
(Figure 1A). There are, however, examples of individuals
who do not have the upstream expansion, but rather
have deletions or point mutations within the FMRP gene
(Hammond et al., 1997). An individual was identified with
an especially severemanifestation of Fragile X syndrome—
low IQ, severe social and behavioral impairment, macro-
orchidism—who had the single point mutation (Ile304Asn)
within the KH2 domain of FMRP (De Boulle et al., 1993).
These observations indicate a key function for FMRP in
normal cells and highlight the importance of the KH do-
mains. There have been a number of suggestions as to
the possible effects of the Ile304Asn mutation on FMRP
function, but no definitive conclusion (Siomi et al., 1994;
Zhang et al., 2001; Wan et al., 2000).
KH modules are widespread, versatile nucleic acid-
binding motifs that most often occur in tandem arrays of
between 2 and 16 repeats. Sequence alignments show
that, typically, the first KH domain (KH1) in a protein is
more similar to other KH1 domains in different proteins
than to KH2, KH3, etc. domains within the same protein.
The same result is found for KH2 and KH3 domains. The
minimal KH motif is comprised of 45 amino acids and is
characterized by a b1a1a2b2 fold, with a consensus
GXXG loop connecting the two central helices (a1 and
a2). KH domains are classified as Type I or Type II folds.
Both contain the minimal KH motif, but with different C-
or N-terminal extensions (underlined) giving b1a1a2b1b’a’
and a’b’b1a1a2b2 for Type I and Type II, respectively (Fig-
ure 2). KH domains in eukaryotic proteins are exclusively
Type I, whereas those in prokaryotic proteins are exclu-
sively Type II (Siomi et al., 1993; Grishin, 2001). AlthoughLtd All rights reserved
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Structure of KH Domains of FMRPFigure 1. Fragile X Mental Retardation Protein
(A) Domain organization of human FMRP. The red asterisk indicates the location of the point mutation (Ile304Asn), which results in a severe Fragile X
Mental Retardation phenotype in humans.
(B) Sequence alignment of the KH1 and KH2 domains of human FMRP, its autosomal paralogs FXRP1 and FXRP2, and the Drosophila ortholog,
dFXRP. Residues that are identical in three or more of the proteins are colored dark blue; residues that are identical in two of the proteins are colored
light blue. The numbering pertains to the full-length proteins. The KH1 and KH2 domains of hFMRP are underscored in blue and purple, respectively,
and the conserved GXXG loop in each KH domain is boxed. Again, the red asterisk represents the location of Ile304. The secondary structure
elements on top of the sequence alignment are placed with respect to the crystal structure of hFMRP(KH1-KH2D) and are labeled according to stan-
dard KH nomenclature, shown in Figure 2 and discussed in the main text. The black line connecting b2 and b0 in the second KH domain denotes the
variable loop, and the amino acids absent in hFMRP(KH1-KH2D) are denoted by the dotted line.more than 20 high-resolution structures of isolated KH
domains have been reported (Berman et al., 2005), the
only protein for which a structure of tandem KH domains
has been published is the prokaryotic protein NusA, in
which there are two tandem Type II KH domains (Gopal
et al., 2001; Beuth et al., 2005).Structure 15, 1090–1098Here, to our knowledge, we present the first structure of
tandem, Type I KH domains from the eukaryotic protein
FMRP (Figure 3A). The structure of the tandem KH do-
mains of FMRP reveals that residue Ile304 is solvent inac-
cessible and is part of the hydrophobic core of the protein.
Ile304 is therefore unlikely to be involved in direct contactsFigure 2. KH Fold
(A and B) Stylized representation of (A) the
eukaryotic (Type I) KH domain and (B) the pro-
karyotic (Type II) KH domain. The labeling of
secondary structure elements is done accord-
ing to standard KH nomenclature. The dotted
line connecting b2 and b0 represents the vari-
able loop. The white line connecting helices
a1 and a2 represents the GXXG loop., September 2007 ª2007 Elsevier Ltd All rights reserved 1091
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Structure of KH Domains of FMRPFigure 3. Crystal Structure of hFMRP(KH1-KH2D) and NusA(KH1-KH2)
(A) The KH1 and KH2 domains of hFMRP(KH1-KH2D) are colored blue and purple, respectively. See Table 1 for salient crystallographic statistics.
(B) NusA(KH1-KH2); PDB ID 1K0R. The KH1 and KH2 domains are colored light and dark gray, respectively.
(C) Cartoon representation of hFMRP(KH1-KH2D) and NusA(KH1-KH2) protein (PDB ID: 1K0R). Each KH domain is represented as an oval; the three-
stranded b sheet is shaded in solid black, and the three a helices that pack against the b sheet are shaded with stripes.to ligand, unless there are substantial structural rearrange-
ments upon ligand binding. Furthermore, we show that
mutation of Ile304 to Asn both perturbs the structure of
the protein and decreases its stability.
RESULTS AND DISCUSSION
Structure of hFMRP(KH1-KH2D)
The crystallized construct has a shortened variable loop
between b sheets b2 and b0 in KH2, and we refer to it as
hFMRP(KH1-KH2D). We made many different constructs
of the KH1-KH2 domains of human FMRP, FXRP1,
FXRP2, and dFXRP, but only hFMRP(KH1-KH2D) gave
diffraction-quality crystals. The sequence of this construct
as well as its relationship to the Drosophila ortholog
(dFXRP) and the human paralogs FXRP1 and FXRP2 are
shown in Figure 1B. The structure was phased with multi-
wavelength anomalous diffraction data from selenome-
thionine-substituted protein and was refined to Rwork =
23.0 and Rfree = 28.6, at 1.9 A˚ resolution (Table 1). The
KH1 and KH2 domains of hFMRP(KH1-KH2D) both adopt
a Type I fold, in which a b sheet composed of three anti-
parallel strands is abutted by three a helices (a1, a2, and
a0). The main hydrophobic core of the domain comprises
the buried hydrophobic residues between the hydropho-
bic faces of the b sheet and the a helices (Figure 3A).
The b sheet in each KH domain, described in reference
to standard KH nomenclature (Grishin, 2001), consists of
two parallel, core b strands, b1 and b2, that sandwich
the b0 strand (Figure 2A). This all-antiparallel arrangement
of strands distinguishes the eukaryotic Type I KH fold from
the prokaryotic Type II KH fold, in which b1 and b2 are ad-
jacent and parallel to each other, but in which the b0 strand1092 Structure 15, 1090–1098, September 2007 ª2007 Elsevieis adjacent and antiparallel to b1 (Figure 2B). The length
and sequence of the variable loop are different in different
KHdomains. Although the variable loop in the KH2 domain
of FMRP is truncated to ten amino acids in the construct
crystallized, it still dramatically protrudes from the side
of the domain, whereas the variable loop in KH1 is mark-
edly shorter (Figure 3A).
Comparison of hFMRP(KH1-KH2D) and NusA
KH Domains
Not only is the order of secondary structural units in the
individual KH units of FMRP different from that of prokary-
otic KH domains, but the relative orientation of the KH1
and KH2 domains in hFMRP(KH1-KH2D) is also dramati-
cally different from the orientation of the tandem KH
domains of bacterial protein NusA (Gopal et al., 2001;
Beuth et al., 2005) (Figures 3B and 3C) (PDB ID: 1K0R).
In NusA, an unstructured six amino acid linker connects
KH1 to KH2, and an area of 1380 A˚2 is buried at the
interface between the b sheet of KH1 and the a helices
(a0 and a2) of KH2. By contrast, in hFMRP(KH1-KH2D),
the a0 helix of KH1 is linked to the b1 strand of KH2 by
the single residue Glu280, which adopts non-b, non-a f/
c angles to accomplish this tight connection, and there
are minimal contacts between the KH1 and KH2 domains
(Figures 3A and 3C). These features are consistent with
the fact that the KH1 and KH2 domains of FMRP and its
relatives can be expressed separately.
The tandem arrangement of KH domains in FMRP has
implications for protein function and ligand recognition.
The structure of bacterial NusA in complex with its ligand
shows an extended RNA, which makes contacts with
residues in both the Type II KH1 and KH2 domains (Beuthr Ltd All rights reserved
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Structure of KH Domains of FMRPTable 1. Data Collection and Refinement
Peaka Inflection Remote
Wavelength 0.9788 0.9793 0.9184
Completeness (%) 98.0 (83.8) 98.2 (85.9) 99.2 (95.4)
Resolution (A˚) 50–1.9 (1.97–1.9) 50–1.9 (1.97–1.9) 50–1.9 (1.97–1.90)
Signal/noise (I/s) 19.6 (4.8) 27.3 (3.7) 24.5 (2.9)
Rsym
b (%) 5.0 (18.3) 3.4 (22.3) 3.5 (28.6)
Redundancy 4.6 (4.2) 4.7 (4.1) 4.8 (4.2)
Unique reflections 24,901 24,950 25,337
Refinement
Resolution 1.9 A˚






Bond lengths (A˚) 0.01
Bond angles () 1.4




Ramachandran plot (two complexes per asymmetric unit)
Residues in the most favored regions 235
Residues in the additionally allowed regions 15
Residues in the generously allowed regions 0
Residues in the disallowed regions 0
The values in parentheses are for the highest-resolution bins.
a The model was refined against the peak data set.
b Rsym = ShSijIh,i  <I>hj/jShSiIh,ij, where <I>h is the average intensity of symmetry-related reflections.
c Rfree was calculated the same as Rwork, but on 5% of randomly selected data not used in refinement.et al., 2005). The structures of NusA with and without RNA
bound show no significant changes in protein conforma-
tion upon ligand binding (Beuth et al., 2005; Gopal et al.,
2001). The orientation of the tandem KH domains of
FMRP is different from that seen in NusA; therefore, we
would expect the mode of interaction with ligand to also
be different.
Although no high-resolution structural data are avail-
able, it has been proposed that the Drosophila protein
PSI interacts with its RNA substrate through an elongated
interaction surface that extends across its four Type I KH
domains (Chmiel, et al. 2006). In such amodel, tandemKH
domains function cooperatively. This observation sug-
gests, again, that the orientation of KH domains with
respect to each other is important in ligand binding
(Figure 3C).Structure 15, 1090–1098hFMRP(KH1-KH2D) Is a Monomer in Solution
It has been suggested that KH motifs may be able to
homodimerize (Lewis et al., 1999, 2000; Git and Standart,
2002; Ramos et al., 2002), and that full-length FMRP may
homodimerize through its N-terminal and KH2 domains
(Adinolfi et al., 2003; Ramos et al., 2006), although the
evidence is by no means conclusive. In the crystal struc-
ture we present, there are two molecules in the asymmet-
ric unit related by noncrystallographic symmetry (NCS)
that are close to perpendicular to the two-fold crystallo-
graphic B axis. The interface between the two molecules
has a total buried surface area of 2137 A˚2 and is primarily
formed between NCS-related b2 strands (residues 314–
322) of the KH2 domain. This amount of buried surface
area is well above the accepted minimum of 1200 A˚2 for
a protein-protein dimerization interface (Lo Conte et al.,, September 2007 ª2007 Elsevier Ltd All rights reserved 1093
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Structure of KH Domains of FMRPFigure 4. hFMRP(KH1-KH2D) Behavior
in Solution
(A) The contents of the asymmetric unit (ASU).
There are two molecules in the ASU related by
NCS that are close to perpendicular to the
crystallographic B axis. The KH1 and KH2
domains of one molecule are colored blue
and purple, respectively. The NCS-related
chain is colored in shades of gray.
(B) Representative example of analytical
ultracentrifugation (AUC) data. Protein concen-
tration is plotted versus radius for an AUC equi-
librium experiment. 150 mM and 260 mM
hFMRP(KH1-KH2D) were spun at 10,000,
18,000, 38,000, and 45,000 rpm at 25C. The
solid line shows a fit of the data to a model of
a nonassociating monomer with a molecular
weight of 15,967 (rmsd of 0.007). The molecu-
lar weight of the monomer calculated from its
sequence is 16,037. Residuals are shown at
the bottom of the plot.1999). Moreover, the arrangement creates an extended
b sheet plane composed of six antiparallel strands in the
asymmetric unit. Peptide backbone hydrogen bonding
and cross-strand side chain interactions stabilize the
b sheet (Merkel, et al., 1999) (Figure 4A). Gel-filtration
chromatography, however, showed no indication of
dimerization. We were therefore motivated to determine
the oligomeric state of hFMRP(KH1-KH2D) in solution by
usingmore sensitive means and performed sedimentation
equilibriumultracentrifugationmeasurements over a range
of protein concentrations and rotor speeds. These studies
clearly showed a single species in solution with a molecu-
lar weight consistent with that predicted for the monomer
(Figure 4B). Even at high protein concentrations there was
no indication of higher-molecular weight species. Thus,
the NCS dimer seen in the crystal structure of the KH1-
KH2 domain construct does not represent a dimer that
is stable in solution. This observation does not, of course,
preclude the possibility that the full-length hFMRP is a
dimer, or that there could be KH domain-mediated con-
tacts in such a dimer.
Structural and Solution Characterization
of Ile304Asn
There is special interest in residue Ile304, which is located
in the KH2 domain of FMRP, because an individual with
a particularly severe case of Fragile X syndrome produces
normal levels of a mutant form of FMRP, with the1094 Structure 15, 1090–1098, September 2007 ª2007 ElsevierIle304Asn mutation (De Boulle et al., 1993). Since the
original clinical description, there have been several
hypotheses regarding the possible effect of the Ile304Asn
mutation on protein function. These include the proposal
that the Ile304Asn mutation causes complete unfolding
of the KH2 domain (Musco et al., 1997); that the mutation
has no effect on protein structure, but that it prevents RNA
binding by disrupting a hydrophobic platform on the
protein involved in RNA contact (Lewis et al., 2000); and,
finally, that the mutation causes an alteration in the asso-
ciation of FMRP with other proteins in vivo (Feng et al.,
1997). The controversy surrounding the effect of themuta-
tion derives in part from the fact that data obtained with
different KH domains have been extrapolated to the KH
domains of hFMRP (Lewis et al., 2000; Pozdnyakova
and Regan, 2005; Chmiel et al., 2006).
The structure of hFMRP(KH1-KH2D) that we present
allows us to precisely specify the position of the Ile304 res-
idue in the protein: Ile304 forms part of an extensive net-
work of hydrophobic residues (Val296, Ile307, Val308,
Val316, Ile318, Phe380, Phe382, and Leu395) that stabi-
lize a1, a2, and a0 on the b sheet of the second KH domain
(Figure 5A). This set of hydrophobic residues is conserved
among all known Fragile X-related proteins, including
FXRP1, FXRP2, and dFXRP, suggesting a conservation
of hydrophobic packing and van der Waals interactions
in the core. All of the atoms of Ile304 are completely inac-
cessible to solvent, except for the atom Ile304Cg2, whoseLtd All rights reserved
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Structure of KH Domains of FMRPFigure 5. Structural Analysis of Ile304
(A) Stick representation of the hydrophobic
network of amino acids with experimental elec-
tron density (contoured at s = 1.5) after solvent
flattening and NCS averaging with RESOLVE
(Terwilliger, 2004). The electron density around
residues Val296 and Ile307 is omitted for
clarity. Ile304 is colored red.
(B)CDspectra of hFMRP(KH1-KH2D) (squares)
and hFMRP(KH1-KH2D) Ile304Asn (circles).
Inset: thermal denaturation curves of hFMRP
(KH1-KH2D) (squares) and hFMRP(KH1-
KH2D) Ile304Asn (circles). The solid and dotted
lines show fits to a two-state denaturation tran-
sition for hFMRP(KH1-KH2D) and hFMRP
(KH1-KH2D) Ile304Asn, respectively. We esti-
mate the melting temperature of hFMRP(KH1-
KH2D) as 65C and that of hFMRP(KH1-
KH2D) Ile304Asn as 55C.solvent accessibility is calculated to be less than a third of
that of the Cg2 atom of Ile in an extended Gly-Ile-Gly
environment (CCP4, 1994). This observation indicates
that Ile304 cannot participate in direct contacts with
ligand, unless there are significant structural perturba-
tions. Because Ile304 is an integral component of a buried
network of hydrophobic amino acids, its substitution with
Asn would disrupt the hydrophobic core and destabilize
the protein.
We used circular dichroism (CD) to investigate the effect
of the Ile304Asn mutation on the structure and stability of
hFMRP(KH1-KH2D) in solution. The mutation causes both
a decrease in the secondary structure content of the
protein and a decrease in its stability (Figure 5B). The
CD spectra of hFMRP(KH1-KH2D) Ile304Asn at 4C and
at 25C are identical, indicating that the mutation does
not shift the equilibrium between the folded and unfolded
states of the protein, but rather that it causes a structural
change in the protein (data not shown).
In summary, we present the structure of tandem,
eukaryotic, Type I KH domains. The relative orientationStructure 15, 1090–1098of these tandem domains is quite different from that
observed for tandem, prokaryotic, Type II domains, as
epitomized in the structure of NusA. Most importantly,
the structure of the tandem KH domains of FMRP has
immediate relevance to our understanding of the molecu-
lar basis of Fragile X syndrome. Our results reveal the
location of amino acid Ile304, whose mutation to Asn is
associated with a particularly extreme case of Fragile X
syndrome. Moreover, we show that mutation of Ile304 to
Asn causes significant structural perturbation and desta-
bilization of the protein in vitro, thus providing one plausi-
ble mechanism by which this mutation severely compro-
mises protein function. Future studies will focus on
a better understanding of the normal function of FMRP
and the nature of its RNA ligands.
EXPERIMENTAL PROCEDURES
Molecular Biology
The hFMRP(KH-KH2D) construct corresponds to amino acids 216–
404 of human FMRP (NCBI accession number: AAH86957), with, September 2007 ª2007 Elsevier Ltd All rights reserved 1095
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Structure of KH Domains of FMRPresidues 331–375 deleted from the variable loop of the KH2 domain.
This coding sequence was cloned into the modified vector pET15b
(Novagen; Madison, WI) in which we incorporated an N-terminal His
tag followed by a TEV protease site. The Ile304Asn mutant was gener-
ated from the hFMRP(KH-KH2D) construct, by using Quick Change
mutagenesis (Stratagene; La Jolla, CA), and was verified by DNA
sequencing.
Expression and Purification
Metal affinity purification for hFMRP(KH-KH2D) and hFMRP
(KH-KH2D) Ile304Asn was adapted from previously published
methods (Pozdnyakova and Regan, 2005). Briefly, plasmids were
transformed into BL21 GOLD (DE3) and were grown with shaking in
Luria-Bertani (LB) supplemented with 100 mg/ml ampicillin at 37C to
an OD600 of 0.6, at which point the expression was induced by addition
of isopropyl-b-D-thiogalactopyranoside (IPTG) to a final concentration
of 1mM. The temperature was then lowered to 25C, and growth con-
tinued for 5 more hr.
Cells were harvested by centrifugation, resuspended in 50 mM Tris-
HCl (pH 8.0), 300 mM NaCl, 5 mM b-mercaptoethanol, 10 mM Imidaz-
ole, 20% glycerol containing lysozyme (1 mg/ml) and complete EDTA-
free protease inhibitor cocktail (Roche; Basel, Switzerland), and lysed
by sonication. Debris was removed by centrifugation. The soluble su-
pernatant fraction of the whole-cell lysate was incubated with TALON
metal affinity resin (BD Biosciences Clonetech; Palo Alto, CA) for 45
min at 4C. His-tagged protein was eluted with elution buffer (50 mM
Tris-HCl [pH 8.0], 300 mM NaCl, 5 mM b-mercaptoethanol, 250 mM
imidazole, 5% glycerol). The N-terminal His tag was then removed
by digestion with TEV protease (Invitrogen; Carlsbad, CA). After TEV
protease digestion, the sample was passed over a second TALON
metal affinity column to remove the cleaved His tags and the TEV pro-
tease (which is also His tagged). Fractions of hFMRP(KH-KH2D) or
hFMRP(KH-KH2D)-Ile304Asn with no tag were then pooled, concen-
trated (Centriprep YM-10; Fisher Scientific; Pittsburg, PA), and loaded
onto a gel-filtration column (High-load Superdex RH-75 column, Amer-
sham Biosciences; Piscataway, NJ) equilibrated with 50 mM Tris-HCl
(pH 8.0), 300 mM NaCl, 5 mM L-glutathione. The identity and purity of
the KH-containing fractions were checked by SDS-PAGE, and the
fractions containing isolated protein sample were pooled and further
concentrated by Centriprep-YM-10 to a final concentration of approx-
imately 32–36 mg/ml. The protein concentration was determined from
absorption at 280 nm (the extinction coefficient was determined by
amino acid composition analysis by using the PROTPARAM tool;
http://ca.expasy.org/ [Gasteiger et al., 2003]).
Selenomethionine (SeMet)-substituted hFMRP(KH1-KH2D) was
produced as follows. The B834(DE3) Escherichia coli auxotroph was
transformed with plasmid and grown in M9 media supplemented
with 50 mg ml1 L-methionine at 37C. At an OD600 of 0.6 cells were
spun down and resuspended in M9 media supplemented with 50 mg
ml1 of L-selenomethionine. IPTGwas then added to a final concentra-
tion of 0.7 mM, and growth continued for an additional 17 hr at 30C.
Cell harvesting and protein purification proceeded as described for
unlabeled protein.
Crystallization of hFMRP(KH1-KH2D)
Crystals of hFMRP(KH-KH2D) (wild-type and SeMet-substituted) grew
rapidly (in 8 hr) when the hanging-drop vapor-diffusion method was
used. Protein concentration was 32–36 mg/ml in 50 mM Tris-HCl (pH
8.0), 300 mMNaCl, and 5 mM reduced L-glutathione. The well solution
consisted of 0.1 M Tris-HCl (pH 7.5–8.5), 0.2 M MgCl, and PEG 4000
27%–30%. Single crystals were prepared for data collection by fast
transfer into cryoprotectant, Paratone-N (Hampton Research), and
were immediately frozen in the cryostream. Crystals grew in the space
group C2 with unit cell dimensions of a = 71.0 A˚, b = 70.7 A˚, c = 68.2 A˚,
and b = 107.2 A˚; there were two molecules in the asymmetric unit.1096 Structure 15, 1090–1098, September 2007 ª2007 ElsevieData Collection, Structure Determination, and Refinement
All data were collected at beamline X6A, National Synchrotron Light
Source, Brookhaven from a single SeMet-substituted protein crystal
(Table 1). Peak, remote, and inflection data sets were scaled and inte-
grated with the HKL2000 program suite (Otwinowski and Minor, 1997).
The structure was phased with SeMet multiwavelength anomalous
diffraction (MAD) data at 2.5 A˚ by using SOLVE (Terwilliger, 2004).
Four Se sites in the asymmetric unit were found with a figure of merit
of 0.65. Solvent flattening, two-fold noncrystallographic symmetry
averaging, and phase extension to 1.9 A˚ in RESOLVE (Terwilliger,
2004) produced an interpretable map that was used in building the
structure. The model was traced in O (Jones et al., 1991) by using
simulated annealing composite-omit maps calculated by using CNS
(Brunger et al., 1998).
Water molecules were added in two cycles of ARP/wARP (CCP4,
1994) and were validated by using Fourier difference maps and
COOT (Emsley and Cowtan, 2004). Iterative rounds of restrained
refinement in REFMAC5 (CCP4, 1994) and model adjusting in COOT
were carried out until R factors dropped to acceptable values for
a structure of this resolution (Kleywegt and Jones, 2002). A TLS model
(Painter and Merritt, 2006) was used in the late stages of refinement.
The stereochemical quality of the model was inspected by using Pro-
Check and Molprobity (Lovell et al., 2003). Figures were made with the
help of PyMOL (DeLano, 2002). Solvent-accessible areas were calcu-
lated with AREAIMOL (CCP4, 1994) (comparison with other structures
was performed using DALI, see the Supplemental Data available with
this article online).
Circular Dichroism
This protocol was adapted from a previously published method (Pozd-
nyakova and Regan, 2005). Briefly, CD spectra were recorded in a
0.1 cm path-length cuvette by using AVIV spectrophotometer Model
215 (AVIV Instruments, Inc.) at 25C. Protein samples were diluted in
CD buffer (10 mM HEPES [pH 7.5], 30 mM NaCl) to a final concentra-
tion of 25 mM, as determined by amino acid analysis. For each sample
spectrum recorded, a buffer blank was subtracted from the raw signal,
and, subsequently, mean residue ellipticity was calculated. Thermal
denaturation transitions were monitored by CD absorption at
222 nm. Thermal scans were performed in forward and reverse direc-
tions from 4C to 95C in 1C steps with a 3 min equilibration time at
each temperature.
Analytical Ultracentrifugation
Sedimentation equilibrium was performed on a Beckman XL-I analyt-
ical ultracentrifuge at 25C by using an AN 60-Ti 4-hole rotor equipped
with six-channel, carbon-epoxy composite centerpieces (Beckman
Coulter). hFRMP(KH1-KH2D) was resuspended in AUC buffer
(150 mM NaCl, 50 mM HEPES [pH 8.0], 1 mM TCEP [pH 7.0] [Pierce;
Rockford, IL]) at 150 mM and 260 mM. Approximately 120 ml of each
sample was spun at 10,000, 18,000, 38,000, and 45,000 rpm and
was allowed to reach equilibrium, which took about 24 hr in each
case. Sedimentation equilibrium curves were measured by absor-
bance at 280 nm, and successive scans were taken at 2 hr intervals.
Attainment of equilibrium for every speedwas confirmed by comparing
the radial concentration profile in eight successive scans by using the
MATCH program. For each sample, the various data sets were fitted
both individually for each speed and simultaneously at all speeds by
using HeteroAnalysis software (Cole, 2004) (V1.1.19, by James Cole
and Jeffery Lary, Analytical Ultracentrifugation Facility, Biotechnology
and Bioservices Center, University of Connecticut, Storrs, CT). Two
fitting models were used; one is the ideal model, which assumes that
the solution is ideal with single species, while the second model as-
sumed monomer-dimer equilibria and a fixed monomer molecular
weight of 16,037, as calculated from the amino acid sequences. The
viscosity of the buffer at 25C was calculated to be 1 mg/ml, and the
partial specific volume for hFMRP(KH1-KH2D) was calculated on
the basis of amino acid composition as 0.727 ml/mg.r Ltd All rights reserved
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